173039-06-0

Basic information

• Product Name: dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate
• Synonyms: dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate
• CAS NO: 173039-06-0
• Molecular Weight: 586.621
• Mol File: 173039-06-0.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate(CAS DataBase Reference)
• NIST Chemistry Reference: dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate(173039-06-0)
• EPA Substance Registry System: dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate(173039-06-0)

Safety Data

• Hazardous Substances Data: 173039-06-0(Hazardous Substances Data)

Upstream product

• 538-60-3 dibenzyl hydrogen phosphite 
• 75-24-1 trimethylaluminum 
• 173039-05-9 dibenzyl 2-methylenepentanedioate 
• 2495-35-4 benzylacrylate 

Downstream Products

• 173039-10-6 2-(phosphonomethyl)pentanedioic acid 

Relevant articles and documents

Prodrugs of NAALAdase inhibitors

The present invention relates to prodrugs of NAALADase inhibitors, pharmaceutical compositions comprising the same, and methods of using the same to treat glutamate abnormalities and prostate diseases.

Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors

The present invention relates to methods of using NAALADase inhibitors for treating glutamate-mediated diseases, disorders and conditions selected from the group consisting of anxiety, anxiety disorders and memory impairment.

Methods of cancer treatment using naaladase inhibitors

The present disclosure relates to dipeptidase inhibitors, and more particularly, to novel methods of using phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives to inhibit N-Acetylated alpha -Linked Acidic Dipeptidase (NA